These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 23011084)
1. Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis. Jude C; Dejica D; Samasca G; Balacescu L; Balacescu O Rheumatol Int; 2013 Apr; 33(4):1031-7. PubMed ID: 23011084 [TBL] [Abstract][Full Text] [Related]
2. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs. Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601 [TBL] [Abstract][Full Text] [Related]
3. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. Greisen SR; Moller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Jørgensen A; Hvid M; Deleuran B Clin Exp Rheumatol; 2011; 29(4):689-92. PubMed ID: 21813065 [TBL] [Abstract][Full Text] [Related]
4. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432 [TBL] [Abstract][Full Text] [Related]
5. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue. Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis. Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700 [TBL] [Abstract][Full Text] [Related]
7. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis. Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971 [TBL] [Abstract][Full Text] [Related]
9. Levels of soluble CD163 and severity of malaria in children in Ghana. Kusi KA; Gyan BA; Goka BQ; Dodoo D; Obeng-Adjei G; Troye-Blomberg M; Akanmori BD; Adjimani JP Clin Vaccine Immunol; 2008 Sep; 15(9):1456-60. PubMed ID: 18632918 [TBL] [Abstract][Full Text] [Related]
10. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment. Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015 [TBL] [Abstract][Full Text] [Related]
11. Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury. Craig DG; Lee P; Pryde EA; Hayes PC; Simpson KJ Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1395-404. PubMed ID: 24138337 [TBL] [Abstract][Full Text] [Related]
12. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection. Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus. Nishino A; Katsumata Y; Kawasumi H; Hirahara S; Kawaguchi Y; Yamanaka H Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel. Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354 [TBL] [Abstract][Full Text] [Related]
15. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604 [TBL] [Abstract][Full Text] [Related]
16. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus. Dultz G; Gerber L; Farnik H; Berger A; Vermehren J; Pleli T; Zeuzem S; Piiper A; Kronenberger B; Waidmann O J Viral Hepat; 2015 Apr; 22(4):427-32. PubMed ID: 25181653 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients. Tanimura H; Mizuno K; Okamoto H Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688 [TBL] [Abstract][Full Text] [Related]
18. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670 [TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of soluble CD163 in patients with scleroderma. Shimizu K; Ogawa F; Yoshizaki A; Akiyama Y; Kuwatsuka Y; Okazaki S; Tomita H; Takenaka M; Sato S Clin Rheumatol; 2012 Jul; 31(7):1059-64. PubMed ID: 22453843 [TBL] [Abstract][Full Text] [Related]
20. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications. Tantawy AA; Adly AA; Ismail EA Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]